Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study

BACKGROUND: Patients who undergo hemodialysis (HD) or kidney transplantation (KTx) previously had limited possibilities for treatment of hepatitis C virus (HCV) infection. Direct-acting antivirals (DAA) give these patients a chance of virus eradication and safe transplantation. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Tronina, Olga, Durlik, Magdalena, Orłowska, Iwona, Lorenc, Beata, Łapiński, Tadeusz W., Garlicki, Aleksander, Dybowska, Dorota, Zarębska-Michaluk, Dorota, Tudrujek-Zdunek, Magdalena, Citko, Jolanta, Janczewska, Ewa, Kaczmarczyk, Marcin, Jaroszewicz, Jerzy, Krygier, Rafał, Klapaczyński, Jakub, Dobracka, Beata, Białkowska-Warzecha, Jolanta, Piekarska, Anna, Simon, Krzysztof, Halota, Waldemar, Pawłowska, Małgorzata, Tomasiewicz, Krzysztof, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079881/
https://www.ncbi.nlm.nih.gov/pubmed/33948071
http://dx.doi.org/10.20524/aog.2021.0595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079881/
https://www.ncbi.nlm.nih.gov/pubmed/33948071
http://dx.doi.org/10.20524/aog.2021.0595

Ejemplares similares